{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:29:36Z","timestamp":1787614176477,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Multiple sclerosis is an autoimmune neurodegenerative disease of the central nervous system characterized by pronounced inflammatory infiltrates entering the brain, spinal cord and optic nerve leading to demyelination. Focal demyelination is associated with relapsing-remitting multiple sclerosis, while progressive forms of the disease show axonal degeneration and neuronal loss. The tests currently used in the clinical diagnosis and management of multiple sclerosis have limitations due to specificity and sensitivity. MicroRNAs (miRNAs) are dysregulated in many diseases and disorders including demyelinating and neuroinflammatory diseases. A review of recent studies with the experimental autoimmune encephalomyelitis animal model (mostly female mice 6\u201312 weeks of age) has confirmed miRNAs as biomarkers of experimental autoimmune encephalomyelitis disease and importantly at the pre-onset (asymptomatic) stage when assessed in blood plasma and urine exosomes, and spinal cord tissue. The expression of certain miRNAs was also dysregulated at the onset and peak of disease in blood plasma and urine exosomes, brain and spinal cord tissue, and at the post-peak (chronic) stage of experimental autoimmune encephalomyelitis disease in spinal cord tissue. Therapies using miRNA mimics or inhibitors were found to delay the induction and alleviate the severity of experimental autoimmune encephalomyelitis disease. Interestingly, experimental autoimmune encephalomyelitis disease severity was reduced by overexpression of miR-146a, miR-23b, miR-497, miR-26a, and miR-20b, or by suppression of miR-182, miR-181c, miR-223, miR-155, and miR-873. Further studies are warranted on determining more fully miRNA profiles in blood plasma and urine exosomes of experimental autoimmune encephalomyelitis animals since they could serve as biomarkers of asymptomatic multiple sclerosis and disease course. Additionally, studies should be performed with male mice of a similar age, and with aged male and female mice.<\/jats:p>","DOI":"10.4103\/1673-5374.280307","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T15:00:30Z","timestamp":1585926030000},"page":"1831-1837","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis"],"prefix":"10.4103","volume":"15","author":[{"given":"Bridget","family":"Martinez","sequence":"first","affiliation":[{"name":"Physical Chemistry and Applied Spectroscopy, Chemistry Division, Los Alamos National Laboratory, Los Alamos, NM, USA"},{"name":"Department of Medicine, St. Georges University School of Medicine, Grenada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5468-1989","authenticated-orcid":false,"given":"Philip V.","family":"Peplow","sequence":"additional","affiliation":[{"name":"Department of Anatomy, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"R1-20260525","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nbd.2014.08.003","article-title":"MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions","volume":"71","author":"Andersen","year":"2014","journal-title":"Neurobiol Dis"},{"key":"R2-20260525","first-page":"668","article-title":"Immunological markers for PML prediction in MS patients treated with natalizumab","volume":"5","author":"Antoniol","year":"2014","journal-title":"Front Immunol"},{"key":"R3-20260525","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B","article-title":"Neurologic disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients","volume":"48","author":"Bjartmar","year":"2000","journal-title":"Ann Neurol"},{"key":"R4-20260525","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science"},{"key":"R5-20260525","first-page":"311","article-title":"MicroRNA dysregulation in multiple sclerosis","volume":"3","author":"de Faria","year":"2012","journal-title":"Front Genet"},{"key":"R6-20260525","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"R7-20260525","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"R9-20260525","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroscience.2017.07.033","article-title":"Chronic mild stress exacerbates severity of experimental autoimmune encephalomyelitis in association with altered non-coding RNA and metabolic biomarkers","volume":"359","author":"Gerrard","year":"2017","journal-title":"Neuroscience"},{"key":"R10-20260525","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fimmu.2017.00758","article-title":"MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune neuroinflammation","volume":"8","author":"Ghorbani","year":"2017","journal-title":"Front Immunol"},{"key":"R11-20260525","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol Cell"},{"key":"R12-20260525","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front Genet"},{"key":"R13-20260525","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1756285613488434","article-title":"Sex and gender issues in multiple sclerosis","volume":"6","author":"Harbo","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"key":"R14-20260525","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0095-4543(03)00123-4","article-title":"Multiple sclerosis","volume":"31","author":"Hawker","year":"2004","journal-title":"Prim Care"},{"key":"R15-20260525","doi-asserted-by":"crossref","first-page":"e25456","DOI":"10.1371\/journal.pone.0025456","article-title":"Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation","volume":"6","author":"Herges","year":"2011","journal-title":"PLoS One"},{"key":"R16-20260525","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-2094-10-120","article-title":"Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model","volume":"10","author":"Horstmann","year":"2013","journal-title":"J Neuroinflammation"},{"key":"R17-20260525","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/hmg\/ddy085","article-title":"Increased expression of microRNA-15a and microRNA-15b in skeletal muscle from adult offspring of women with diabetes in pregnancy","volume":"27","author":"Houshmand-Oeregaard","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R18-20260525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2015.06.015","article-title":"Biomarkers in multiple sclerosis","volume":"161","author":"Housley","year":"2015","journal-title":"Clin Immunol"},{"key":"R19-20260525","doi-asserted-by":"crossref","first-page":"e0130251","DOI":"10.1371\/journal.pone.0130251","article-title":"Treatment of chronic experimental autoimmune encephalomyelitis with epigallocatechin-3-gallate and glatiramer acetate alters expression of heme-oxygenase-1","volume":"10","author":"Janssen","year":"2015","journal-title":"PLoS One"},{"key":"R20-20260525","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.1038\/s41598-018-31542-y","article-title":"Neuronal microRNA regulation in experimental autoimmune encephalomyelitis","volume":"8","author":"Ju\u017awik","year":"2018","journal-title":"Sci Rep"},{"key":"R21-20260525","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1523\/JNEUROSCI.4794-14.2015","article-title":"Dysregulated RNA-induced silencing complex (RISC) assembly within CNS corresponds with abnormal miRNA expression during autoimmune demyelination","volume":"35","author":"Lewkowicz","year":"2015","journal-title":"J Neurosci"},{"key":"R22-20260525","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/01.wnl.0000210506.00078.5c","article-title":"MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability","volume":"66","author":"Li","year":"2006","journal-title":"Neurology"},{"key":"R23-20260525","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/cr.2016.32","article-title":"CCAR1 5\u2019 UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance","volume":"26","author":"Li","year":"2016","journal-title":"Cell Res"},{"key":"R24-20260525","doi-asserted-by":"crossref","first-page":"28971","DOI":"10.1074\/jbc.M114.577429","article-title":"Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme","volume":"289","author":"Liu","year":"2014","journal-title":"J Biol Chem"},{"key":"R25-20260525","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2018.04.016","article-title":"Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets","volume":"428","author":"Long","year":"2018","journal-title":"Cancer Lett"},{"key":"R26-20260525","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7150\/ijms.8647","article-title":"Expression, regulation and function of microRNAs in multiple sclerosis","volume":"11","author":"Ma","year":"2014","journal-title":"Int J Med Sci"},{"key":"R27-20260525","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4103\/1673-5374.272572","article-title":"Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019","volume":"15","author":"Martinez","year":"2020","journal-title":"Neural Regen Res"},{"key":"R28-20260525","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4103\/1673-5374.280307","article-title":"MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression","volume":"15","author":"Martinez","year":"2020","journal-title":"Neural Regen Res"},{"key":"R30-20260525","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/brain\/awz245","article-title":"MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis","volume":"142","author":"Morquette","year":"2019","journal-title":"Brain"},{"key":"R33-20260525","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/1352458513505353","article-title":"JC-virus conversion in multiple sclerosis patients receiving natalizumab","volume":"20","author":"Outteryck","year":"2014","journal-title":"Mult Scler"},{"key":"R34-20260525","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ncl.2004.09.008","article-title":"Neuropathobiology of multiple sclerosis","volume":"23","author":"Peterson","year":"2005","journal-title":"Neurol Clin"},{"key":"R35-20260525","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Plavina","year":"2014","journal-title":"Ann Neurol"},{"key":"R36-20260525","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10753-018-0887-3","article-title":"MicroRNA-92a drives Th1 responses in the experimental autoimmune encephalomyelitis","volume":"42","author":"Rezaei","year":"2019","journal-title":"Inflammation"},{"key":"R37-20260525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fimmu.2019.00015","article-title":"Cytokine targeting by miRNAs in autoimmune diseases","volume":"10","author":"Salvi","year":"2019","journal-title":"Front Immunol"},{"key":"R38-20260525","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imm.12611","article-title":"MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice","volume":"148","author":"Satoorian","year":"2016","journal-title":"Immunology"},{"key":"R39-20260525","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jneuroim.2018.06.010","article-title":"MicroRNA-150 targets PU. 1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis","volume":"323","author":"Shakerian","year":"2018","journal-title":"J Neuroimmunol"},{"key":"R40-20260525","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/cmi.2017.12","article-title":"IL-17-triggered downregulation of miR-497 results in high HIF-1\u03b1 expression and consequent IL-1\u03b2 and IL-6 production by astrocytes in EAE mice","volume":"14","author":"Shan","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"R41-20260525","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11481-015-9630-0","article-title":"Targeted stage-specific inflammatory microRNA profiling in urine during disease progression in experimental autoimmune encephalomyelitis: markers of disease progression and drug response","volume":"11","author":"Singh","year":"2016","journal-title":"J Neuroimmune Pharmacol"},{"key":"R42-20260525","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R43-20260525","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12974-017-0832-7","article-title":"MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis","volume":"14","author":"Talebi","year":"2017","journal-title":"J Neuroinflammation"},{"key":"R44-20260525","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.3389\/fimmu.2018.02784","article-title":"Tuftsin combines with remyelinating therapy and improves outcomes in models of CNS demyelinating disease","volume":"9","author":"Thompson","year":"2018","journal-title":"Front Immunol"},{"key":"R45-20260525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","article-title":"Epidemiology and treatment of multiple sclerosis in elderly populations","volume":"15","author":"Vaughn","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"R46-20260525","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.3390\/ijms19123990","article-title":"The miRNA expression profile of experimental autoimmune encephalomyelitis reveals novel potential disease biomarkers","volume":"19","author":"Venkatesha","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R47-20260525","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/eji.201948111","article-title":"MicroRNA 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 alpha in experimental autoimmune encephalomyelitis","volume":"49","author":"Wan","year":"2019","journal-title":"Eur J Immunol"},{"key":"R48-20260525","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/jcbfm.2014.207","article-title":"Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-KB activation","volume":"35","author":"Wu","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"R49-20260525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jnen\/61.1.23","article-title":"Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis","volume":"61","author":"Wujek","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"R50-20260525","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","article-title":"MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"266","author":"Zhang","year":"2014","journal-title":"J Neuroimmunol"},{"key":"R51-20260525","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2019.01.019","article-title":"MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis","volume":"125","author":"Zhang","year":"2019","journal-title":"Neurobiol Dis"},{"key":"R52-20260525","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12017-014-8335-5","article-title":"miR26a modulates Th17\/Treg balance in the EAE model of multiple sclerosis by targeting IL6","volume":"17","author":"Zhang","year":"2015","journal-title":"Neuromolecular Med"},{"key":"R53-20260525","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ymthe.2017.11.013","article-title":"miR-23b suppresses leukocyte migration and pathogenesis of experimental autoimmune encephalomyelitis by targeting CCL7","volume":"26","author":"Zhang","year":"2018","journal-title":"Mol Ther"},{"key":"R54-20260525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbi.2018.03.011","article-title":"MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis","volume":"70","author":"Zhang","year":"2018","journal-title":"Brain Behav Immun"},{"key":"R55-20260525","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.4049\/jimmunol.1303488","article-title":"miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting ROR\u03b3t and STAT3","volume":"192","author":"Zhu","year":"2014","journal-title":"J Immunol"},{"key":"R56-20260525","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1177\/1051228405283291","article-title":"Clinical-magnetic resonance imaging corelations in multiple sclerosis","volume":"15","author":"Zivadinov","year":"2005","journal-title":"J Neuroimaging"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.280307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:29Z","timestamp":1786735769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.280307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.280307","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"2019-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}